Health Matters for Women - November 2022

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]



November 2022 

New from CDC Authors


New Hear Her™ American Indian and Alaska Native Maternal Health Resources Available

The National Indian Health Board and Office of Minority Health in partnership with the CDC has launched a new segment of the Hear Her™ campaign to amplify the voices of American Indian/Alaska Native people and work to improve maternal health outcomes. 


Crush: A Randomized Trial to Evaluate the Impact of a Mobile Health App on Adolescent Sexual Health

Mobile technology allows delivery of sexual and reproductive health (SRH) information directly to youth. This study tested the efficacy of Crush, a mobile application aimed at improving sexual health by promoting the use of SRH services and contraception among female adolescents ages 14-18 years. 


2gether: A Clinic-Based Intervention to Increase Dual Protection from Sexually Transmitted Infections and Pregnancy in Young African American Females

The purpose of this investigation is to determine whether the 2gether intervention increases use of a dual protection ( concurrent prevention of pregnancy and sexually transmitted infections [STIs]) strategy and decreases pregnancy and STIs among young African American females, who disproportionately experience these outcomes.


Use Trends and Recent Expenditures for Cervical Cancer Screening-Associated Services in Medicare Fee-for-Service Beneficiaries Older Than 65 Years

The objective of this study is to examine annual use trends in cervical cancer screening-associated services, specifically cytology and human papillomavirus (HPV) tests, colposcopy, and cervical procedures loop electrosurgical excision procedure, cone biopsy, and ablation) in Medicare fee-for-service beneficiaries during January 1, 1999, to December 31, 2019, and estimate expenditures for services performed in 2019.


Increased Levels of Anti-PfCSP Antibodies in Post-Pubertal Females Versus Males Immunized with PfSPZ Vaccine Does Not Translate Into Increased Protective Efficacy

While prior research has shown differences in the risk of malaria infection and sickness between males and females, little is known about sex differences in vaccine-induced immunity to malaria. This study seeks to identify such differences in order to elucidate important aspects of malaria biology and facilitate development of improved approaches to malaria vaccination.


Influenza Vaccination During Pregnancy and Risk of Selected Major Structural Congenital Heart Defects, National Birth Defects Prevention Study 2006-2011

Although results from studies of first-trimester influenza vaccination and congenital heart defects (CHDs) have been reassuring, data are limited for specific CHDs. This study assessed associations between reported maternal influenza vaccination, 1 month before pregnancy through end of third pregnancy month (P3), and specific CHDs using data from a multisite, population-based case-control study.


Embryo Donation: National Trends and Outcomes, 2004-2019

The objective of this study is to examine trends in utilization of embryo donation, pregnancy rates and live birth rates per transfer between 2004-2019 and to update current information regarding characteristics and outcomes of embryo donation cycles in order to benefit patients and providers during counseling and decision making.


Timing of Positive Hepatitis C Virus Test Results During and 1 Year Before Pregnancy

The incidence of hepatitis C virus (HCV) infection in reproductive-aged adults quadrupled during the past decade. Hepatitis C can progress to advanced liver disease and be transmitted perinatally. Highly effective curative hepatitis C treatment is available but is not recommended in pregnancy. Using the Surveillance for Emerging Threats to Mothers and Babies Network, this study describes timing of positive RNA testing among pregnant people with HCV (HCV RNA detected during or within one year prior to pregnancy).

If you're having trouble reading this message, click here

This service is provided by the CDC/ATSDR Office of Women's Health. Email comments or suggestions to owh@xxxxxxx.

For more information about women’s health, visit www.cdc.gov/women.

Disclaimer:

The findings and conclusions in this report are those of the author(s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention. Links to non-Federal organizations are provided solely as a service to our users. These links do not constitute an endorsement of these organizations or their programs by CDC/ATSDR or the Federal Government, and none should be inferred. The CDC/ATSDR is not responsible for the content of the individual organization Web pages found at these links.

Centers for Disease Control and Prevention

1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348
Questions or Problems  | 


[Index of Archives]     [NIH News]     [FDA News]     [USDA News]     [Yosemite News]     [Steve's Art]     [SB Lupus]     [STB]
  Powered by Linux